Patent policy and public health in developing countries: lessons from Japan
スポンサーリンク
概要
- 論文の詳細を見る
リンクされているPDFはWeb版。Referencesが増補されているため印刷版より1ページ多い。The introduction of pharmaceutical product patents in India and other developing countries is expected to have a significant effect on public health and local pharmaceutical industries. This paper draws implications from the historical experience of Japan when it introduced product patents in 1976. In Japan, narrow patents and promotion of cross-licensing were effective tools to keep drug prices in check while ensuring the introduction of new drugs. While the global pharmaceutical market surrounding India today differs considerably from that of the 1970's, the Japanese experience offers a policy option that may profitably be considered by India today. The Indian patent system emphasizes the patentability requirement in contrast to the Japanese patent policy which relied on narrow patents and extensive licensing. R&D by local firms and the development of local products may be promoted more effectively under the Japanese model.
論文 | ランダム
- 福山市在住高齢者の日常生活における外出について
- 水道水中の放射性物質の概要と課題 (特集 東日本大震災特集 放射性物質の健康影響)
- NEWS SCAN ノーベル賞 化学賞 準結晶の発見者が単独受賞
- 日本の科学者たち--ノーベル賞受賞者を振り返る(4)2002年物理学賞
- ノーベル賞110周年 ノーベル賞の化学への貢献とは (特集 化学 温故知新--記念年に振り返る,その業績が科学に与えた影響)